Main » News
Hidden Morbidity in Cancer: Spouse Caregivers [Íîâîñòü äîáàâëåíà - 19.10.2007] Journal of Clinical Oncology, Vol 25, No 30 (October 20), 2007: pp. 4829-4834 © 2007 American Society of Clinical Oncology. DOI: 10.1200/JCO.2006.10.0909
Hidden Morbidity in Cancer: Spouse CaregiversFrom the Sharett Institute of Oncology, Hadassah University Hospital, Jerusalem; Psychology Department, Bar-Ilan University, Ramat-Gan, Israel; Behavioral Sciences and Health Research Division, Toronto General Hospital, University Health Network; Psychosocial Oncology and Palliative Care Department, Princess Margaret Hospital; and Psychosocial Oncology Research Division, Ontario Cancer Institute, University Health Network, Toronto, Canada Address reprint requests to Michal Braun, PhD, Sharett Institute of Oncology, Hadassah University Hospital, POB 12000, Jerusalem 91120, Israel; e-mail: bmichal2@hadassah.org.il Purpose: This study assesses psychological distress among advanced cancer patients and their spouse caregivers, while examining the relative contribution of caregiving burden and relational variables (attachment orientation and marital satisfaction) to depressive symptoms in the spouse caregivers. Methods: A total of 101 patients with advanced GI or lung cancer and their spouse caregivers were recruited for the study. Measures included Beck Depression Inventory–II (BDI-II), Caregiving Burden scale, Experiences in Close Relationships scale, and ENRICH Marital Satisfaction scale. Results: A total of 38.9% of the caregivers reported significant symptoms of depression (BDI-II Conclusion: Spouse caregivers of patients with advanced cancer are a high-risk population for depression. Subjective caregiving burden and relational variables, such as caregivers' attachment orientations and marital dissatisfaction, are important predictors of caregiver depression. Supported by the Canadian Institutes of Health Research (Grant No. CIHR MOP-62861; G.R.); the Princess Margaret Hospital Foundation, in the memory of Mr. Gerald Kirsh; and from the Department Psychiatry, University Health Network, Toronto, Canada. Presented at the 8th World Congress of Psycho-Oncology, Venice, Italy, October 18-21, 2006. Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||